Magnetic resonance spectroscopy: A basic guide to data acquisition and interpretation

Applied Radiology

Volumn 32, Issue 4, 2003, Pages 25-30

  Wirt, Michael D ^a   Petermann, Gregory W ^b  

^a TRIPLER ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; LACTIC ACID; N ACETYLASPARTIC ACID; TUMOR MARKER;

ARTICLE; BRAIN LEVEL; BRAIN TUMOR; CANCER GRADING; CELL DEATH; CELL DESTRUCTION; CELL WALL; HUMAN; IMAGING SYSTEM; INFORMATION PROCESSING; MULTIPLE SCLEROSIS; NERVE CELL; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRACTICE GUIDELINE; QUALITY CONTROL; RADIATION NECROSIS; RADIOLOGICAL PARAMETERS; SIGNAL NOISE RATIO; STROKE;

EID: 0038408842     PISSN: 01609963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Constantinidis I. MRS methodology. Adv Neurol. 2000;83:235-246.
2. Ballestero J. Essentials of proton magnetic resonance spectroscopy and applications in space-occupying lesions of the brain. Appl Radiol. 2001;30(4):55-63.
3. Danielsen ER, Ross B. Magnetic Resonance Spectroscopy Diagnosis of Neurological Disease. New York: Marcel Dekker, Inc.; 1999.
4. Wiedermann D, Schuff N, Matson GB, et al. Short echo time multi-slice proton magnetic resonance spectroscopic imaging in human brain: Metabolite distributions and reliability. Magn Reson Imaging. 2001;19:1073-1080.
5. Ross B, Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec. 2001;265:54-84.
6. Marshall I, Wardlaw J, Cannon J, et al. Reproducibility of metabolite peak areas in 1H-MRS of the brain. Magn Reson Imaging. 1996;14:281-292.